We are live on ! Find out more
VTVT icon

vTv Therapeutics
VTVT

39 hedge funds and large institutions have $8.1M invested in vTv Therapeutics in 2020 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 12 increasing their positions, 4 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 7

200% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 4

82% more capital invested

Capital invested by funds: $4.44M → $8.1M (+$3.66M)

56% more funds holding

Funds holding: 25 → 39 (+14)

0.06% more ownership

Funds ownership: 0.14% → 0.2% (+0.06%)

Holders
39
Holders Change
+14
Holders Change %
+56%
% of All Funds
0.8%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
21
Increased
12
Reduced
4
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$657K
2
Two Sigma Investments
Two Sigma Investments
New York
+$475K
3
State Street
State Street
Massachusetts
+$435K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$401K
5
Two Sigma Advisers
Two Sigma Advisers
New York
+$311K

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$401K
2
Millennium Management
Millennium Management
New York
-$93K
3
SIM
Spark Investment Management
New York
-$46K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$31K
5
JG
Jefferies Group
New York
-$27K
Name Holding Trade Value Shares
Change 		Change in
Stake
FM
1
Frazier Management
Washington
$2.39M – – –
Vanguard Group
2
Vanguard Group
Pennsylvania
$1.06M +$401K +4,064 +53%
Two Sigma Investments
3
Two Sigma Investments
New York
$1.04M +$475K +4,815 +71%
BlackRock
4
BlackRock
New York
$741K +$657K +6,653 +422%
State Street
5
State Street
Massachusetts
$397K +$435K +4,410 New
Geode Capital Management
6
Geode Capital Management
Massachusetts
$379K +$156K +1,583 +60%
Two Sigma Advisers
7
Two Sigma Advisers
New York
$369K +$311K +3,150 +332%
VF
8
Virtu Financial
New York
$347K +$381K +3,860 New
Northern Trust
9
Northern Trust
Illinois
$313K +$296K +2,995 +619%
Renaissance Technologies
10
Renaissance Technologies
New York
$299K -$401K -4,063 -55%
Squarepoint
11
Squarepoint
New York
$134K +$147K +1,491 New
New York State Common Retirement Fund
12
New York State Common Retirement Fund
New York
$93K +$102K +1,035 New
N
13
Nuveen
North Carolina
$69K +$76.2K +772 New
Bank of New York Mellon
14
Bank of New York Mellon
New York
$55K +$59.4K +602 New
Jane Street
15
Jane Street
New York
$50K +$55.1K +558 New
Charles Schwab
16
Charles Schwab
California
$48K +$51.7K +524 New
WS
17
Wedbush Securities
California
$46K +$14.8K +150 +41%
Goldman Sachs
18
Goldman Sachs
New York
$43K +$1.88K +19 +4%
RhumbLine Advisers
19
RhumbLine Advisers
Massachusetts
$33K +$35.8K +363 New
California State Teachers Retirement System (CalSTRS)
20
California State Teachers Retirement System (CalSTRS)
California
$33K +$36.1K +366 New
AllianceBernstein
21
AllianceBernstein
Tennessee
$28K +$31.1K +315 New
TRCT
22
Tower Research Capital (TRC)
New York
$23K +$25.6K +259 New
JP Morgan Chase
23
JP Morgan Chase
New York
$17K +$19.6K +198 New
AIG
24
American International Group
New York
$13K +$14.6K +148 New
Bank of America
25
Bank of America
North Carolina
$12K -$4.25K -43 -24%
1
2

VTVT Hedge Fund Activity: Q2 2020 in Review

39 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in vTv Therapeutics (VTVT) for Q2 2020, worth a combined $8.1M — up 82% from $4.44M a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new VTVT positions and 7 closed out — a net gain of 14 holders — while 12 added to existing stakes and 4 trimmed.

The largest buyer was BlackRock, adding an estimated $657K. The largest seller was Renaissance Technologies, cutting an estimated $401K.

  • 39 institutional investors held vTv Therapeutics (VTVT) as of Q2 2020, up from 25 in Q1 2020.
  • Funds reported $8.1M of vTv Therapeutics stock for Q2 2020, up 82% quarter-over-quarter.
  • 21 funds opened new vTv Therapeutics positions in Q2 2020 and 7 closed out, a net change of +14 holders.
  • The largest vTv Therapeutics buyer in Q2 2020 was BlackRock, an estimated $657K added.
  • The largest vTv Therapeutics seller in Q2 2020 was Renaissance Technologies, an estimated $401K sold.

Based on aggregated 13F filings for Q2 2020.